Q3TIX9
Gene name |
Usp39 |
Protein name |
U4/U6.U5 tri-snRNP-associated protein 2 |
Names |
Inactive ubiquitin-specific peptidase 39 |
Species |
Mus musculus (Mouse) |
KEGG Pathway |
mmu:28035 |
EC number |
3.4.19.12: Omega peptidases |
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for Q3TIX9
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-Q3TIX9-F1 | Predicted | AlphaFoldDB |
29 variants for Q3TIX9
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| rs3388836957 | 117 | F>Y | No | EVA | |
| rs3388839085 | 129 | H>L | No | EVA | |
| rs3388832250 | 163 | F>S | No | EVA | |
| rs3388839091 | 166 | L>I | No | EVA | |
| rs3388839814 | 171 | F>S | No | EVA | |
| rs3388830495 | 179 | E>D | No | EVA | |
| rs3388834401 | 190 | Y>C | No | EVA | |
| rs3388836984 | 199 | Q>H | No | EVA | |
| rs3388843221 | 209 | K>* | No | EVA | |
| rs3388837050 | 221 | P>S | No | EVA | |
| rs3388839094 | 236 | N>Y | No | EVA | |
| rs3396477791 | 251 | Y>* | No | EVA | |
| rs3396956417 | 254 | E>Q | No | EVA | |
| rs3396916999 | 261 | I>M | No | EVA | |
| rs3396888771 | 262 | K>M | No | EVA | |
| rs3396647133 | 268 | I>M | No | EVA | |
| rs3396963558 | 268 | I>V | No | EVA | |
| rs3388830512 | 289 | F>L | No | EVA | |
| rs3397070101 | 291 | A>V | No | EVA | |
| rs3396966693 | 292 | H>L | No | EVA | |
| rs3388832259 | 323 | S>Y | No | EVA | |
| rs3388836054 | 335 | G>S | No | EVA | |
| rs3388834412 | 345 | N>S | No | EVA | |
| rs3388822748 | 347 | V>I | No | EVA | |
| rs3388839161 | 359 | L>I | No | EVA | |
| rs3412994222 | 461 | F>L | No | EVA | |
| rs3388835700 | 490 | V>I | No | EVA | |
| rs3413069254 | 538 | P>S | No | EVA | |
| rs3388834387 | 539 | Q>L | No | EVA |
No associated diseases with Q3TIX9
Functions
| Description | ||
|---|---|---|
| EC Number | 3.4.19.12 | Omega peptidases |
| Subcellular Localization |
|
|
| PANTHER Family | ||
| PANTHER Subfamily | ||
| PANTHER Protein Class | ||
| PANTHER Pathway Category | No pathway information available | |
4 GO annotations of cellular component
| Name | Definition |
|---|---|
| nucleoplasm | That part of the nuclear content other than the chromosomes or the nucleolus. |
| nucleus | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
| spliceosomal complex | Any of a series of ribonucleoprotein complexes that contain snRNA(s) and small nuclear ribonucleoproteins (snRNPs), and are formed sequentially during the spliceosomal splicing of one or more substrate RNAs, and which also contain the RNA substrate(s) from the initial target RNAs of splicing, the splicing intermediate RNA(s), to the final RNA products. During cis-splicing, the initial target RNA is a single, contiguous RNA transcript, whether mRNA, snoRNA, etc., and the released products are a spliced RNA and an excised intron, generally as a lariat structure. During trans-splicing, there are two initial substrate RNAs, the spliced leader RNA and a pre-mRNA. |
| U4/U6 x U5 tri-snRNP complex | A ribonucleoprotein complex that is formed by the association of the U4/U6 and U5 snRNPs. |
2 GO annotations of molecular function
| Name | Definition |
|---|---|
| cysteine-type deubiquitinase activity | An thiol-dependent isopeptidase activity that cleaves ubiquitin from a target protein to which it is conjugated. |
| zinc ion binding | Binding to a zinc ion (Zn). |
5 GO annotations of biological process
| Name | Definition |
|---|---|
| cell cycle | The progression of biochemical and morphological phases and events that occur in a cell during successive cell replication or nuclear replication events. Canonically, the cell cycle comprises the replication and segregation of genetic material followed by the division of the cell, but in endocycles or syncytial cells nuclear replication or nuclear division may not be followed by cell division. |
| cell division | The process resulting in division and partitioning of components of a cell to form more cells; may or may not be accompanied by the physical separation of a cell into distinct, individually membrane-bounded daughter cells. |
| mRNA splicing, via spliceosome | The joining together of exons from one or more primary transcripts of messenger RNA (mRNA) and the excision of intron sequences, via a spliceosomal mechanism, so that mRNA consisting only of the joined exons is produced. |
| protein deubiquitination | The removal of one or more ubiquitin groups from a protein. |
| spliceosomal complex assembly | The aggregation, arrangement and bonding together of a spliceosomal complex, a ribonucleoprotein apparatus that catalyzes nuclear mRNA splicing via transesterification reactions. |
6 homologous proteins in AiPD
| UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
|---|---|---|---|---|
| Q53GS9 | USP39 | U4/U6.U5 tri-snRNP-associated protein 2 | Homo sapiens (Human) | PR |
| Q8R5K2 | Usp33 | Ubiquitin carboxyl-terminal hydrolase 33 | Mus musculus (Mouse) | PR |
| Q8R5H1 | Usp15 | Ubiquitin carboxyl-terminal hydrolase 15 | Mus musculus (Mouse) | PR |
| Q80U87 | Usp8 | Ubiquitin carboxyl-terminal hydrolase 8 | Mus musculus (Mouse) | PR |
| O88623 | Usp2 | Ubiquitin carboxyl-terminal hydrolase 2 | Mus musculus (Mouse) | PR |
| Q8K387 | Usp45 | Ubiquitin carboxyl-terminal hydrolase 45 | Mus musculus (Mouse) | PR |
| 10 | 20 | 30 | 40 | 50 | 60 |
| MSSRSKRQSH | GSTRGKRESE | SRGSSGRIKK | ERDREKEPEA | ASSRGSPVRV | KREAEPAARE |
| 70 | 80 | 90 | 100 | 110 | 120 |
| VPAPALPVVR | VKREREADED | SEPEREVRAK | NGRVDSEDRR | SRHCPYLDTI | NRSVLDFDFE |
| 130 | 140 | 150 | 160 | 170 | 180 |
| KLCSISLSHI | NAYACLVCGK | YFQGRGLKSH | AYIHSVQFSH | HVFLNLHTLK | FYCLPDNYEI |
| 190 | 200 | 210 | 220 | 230 | 240 |
| IDSSLEDITY | VLKPTFTKQQ | IANLDKQAKL | SRAYDGTTYL | PGIVGLNNIK | ANDYANAVLQ |
| 250 | 260 | 270 | 280 | 290 | 300 |
| ALSNVPPLRN | YFLEEDNYKN | IKRPPGDIMF | LLVQRFGELM | RKLWNPRNFK | AHVSPHEMLQ |
| 310 | 320 | 330 | 340 | 350 | 360 |
| AVVLCSKKTF | QITKQGDGVD | FLSWFLNALH | SALGGTKKKK | KTIVNDVFQG | SMRIFTKKLP |
| 370 | 380 | 390 | 400 | 410 | 420 |
| HPDLPAEEKE | QLLHNDEYQE | TMVESTFMYL | TLDLPTAPLY | KDEKEQLIIP | QVPLFNILAK |
| 430 | 440 | 450 | 460 | 470 | 480 |
| FNGITEKEYK | TYKENFLKRF | QLTKLPPYLI | FCIKRFTKNN | FFVEKNPTIV | NFPITNVDLR |
| 490 | 500 | 510 | 520 | 530 | 540 |
| EYLSEEVQAV | HKNTTYDLIA | NIVHDGKPSE | GSYRIHVLHH | GTGKWYELQD | LQVTDILPQM |
| 550 | 560 | ||||
| ITLSEAYIQI | WKRRDNDETN | QQGA |